Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
University of Nebraska
OncoSec Medical Incorporated
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Soligenix
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Takeda
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Mayo Clinic
Helsinn Therapeutics (U.S.), Inc
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Bausch Health Americas, Inc.
Roswell Park Cancer Institute
Northwestern University
Mayo Clinic
Mayo Clinic
University of Chicago
City of Hope Medical Center
Case Comprehensive Cancer Center
Northwestern University
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Northwestern University
Wake Forest University Health Sciences
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
University of Washington
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)